A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms:
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Washington D.C.
National Research Council
1999
|
| Schlagwörter: | |
| Links: | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 |
| Beschreibung: | Title from caption (viewed June 14, 2001). - "February 1999." Includes bibliographical references This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated |
| Umfang: | 1 Online-Ressource |
| ISBN: | 0309583012 9780309583015 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043142237 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s1999 xx o|||| 00||| eng d | ||
| 020 | |a 0309583012 |c electronic bk. |9 0-309-58301-2 | ||
| 020 | |a 9780309583015 |c electronic bk. |9 978-0-309-58301-5 | ||
| 035 | |a (OCoLC)48629668 | ||
| 035 | |a (DE-599)BVBBV043142237 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 614.59990973 |2 22 | |
| 100 | 1 | |a Gelband, Hellen |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |c Hellen Gelband ; prepared for the National Cancer Policy Board |
| 264 | 1 | |a Washington D.C. |b National Research Council |c 1999 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from caption (viewed June 14, 2001). - "February 1999." | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated | ||
| 650 | 4 | |a Neoplasms / therapy / United States | |
| 650 | 4 | |a Clinical Trials as Topic / standards / United States | |
| 650 | 7 | |a MEDICAL / Preventive Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Forensic Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Public Health |2 bisacsh | |
| 650 | 7 | |a Cancer / Treatment |2 fast | |
| 650 | 7 | |a Clinical trials |2 fast | |
| 650 | 7 | |a Oncology / Research |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cancer |x Treatment | |
| 650 | 4 | |a Oncology |x Research | |
| 650 | 4 | |a Clinical trials | |
| 651 | 4 | |a USA | |
| 710 | 2 | |a National Cancer Policy Board (U.S.) |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028566428 | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 |l DE-1046 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 |l DE-1047 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818981320720646144 |
|---|---|
| any_adam_object | |
| author | Gelband, Hellen |
| author_facet | Gelband, Hellen |
| author_role | aut |
| author_sort | Gelband, Hellen |
| author_variant | h g hg |
| building | Verbundindex |
| bvnumber | BV043142237 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)48629668 (DE-599)BVBBV043142237 |
| dewey-full | 614.59990973 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.59990973 |
| dewey-search | 614.59990973 |
| dewey-sort | 3614.59990973 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02785nam a2200529zc 4500</leader><controlfield tag="001">BV043142237</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s1999 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309583012</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-58301-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309583015</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-58301-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48629668</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043142237</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.59990973</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gelband, Hellen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms</subfield><subfield code="c">Hellen Gelband ; prepared for the National Cancer Policy Board</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington D.C.</subfield><subfield code="b">National Research Council</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from caption (viewed June 14, 2001). - "February 1999."</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Preventive Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Forensic Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Public Health</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oncology / Research</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Board (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028566428</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575</subfield><subfield code="l">DE-1047</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043142237 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T17:29:27Z |
| institution | BVB |
| isbn | 0309583012 9780309583015 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028566428 |
| oclc_num | 48629668 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | National Research Council |
| record_format | marc |
| spelling | Gelband, Hellen Verfasser aut A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms Hellen Gelband ; prepared for the National Cancer Policy Board Washington D.C. National Research Council 1999 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Title from caption (viewed June 14, 2001). - "February 1999." Includes bibliographical references This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated Neoplasms / therapy / United States Clinical Trials as Topic / standards / United States MEDICAL / Preventive Medicine bisacsh MEDICAL / Forensic Medicine bisacsh MEDICAL / Public Health bisacsh Cancer / Treatment fast Clinical trials fast Oncology / Research fast Medizin Cancer Treatment Oncology Research Clinical trials USA National Cancer Policy Board (U.S.) Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 Aggregator Volltext |
| spellingShingle | Gelband, Hellen A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms Neoplasms / therapy / United States Clinical Trials as Topic / standards / United States MEDICAL / Preventive Medicine bisacsh MEDICAL / Forensic Medicine bisacsh MEDICAL / Public Health bisacsh Cancer / Treatment fast Clinical trials fast Oncology / Research fast Medizin Cancer Treatment Oncology Research Clinical trials |
| title | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |
| title_auth | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |
| title_exact_search | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |
| title_full | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms Hellen Gelband ; prepared for the National Cancer Policy Board |
| title_fullStr | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms Hellen Gelband ; prepared for the National Cancer Policy Board |
| title_full_unstemmed | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms Hellen Gelband ; prepared for the National Cancer Policy Board |
| title_short | A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |
| title_sort | a report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms |
| topic | Neoplasms / therapy / United States Clinical Trials as Topic / standards / United States MEDICAL / Preventive Medicine bisacsh MEDICAL / Forensic Medicine bisacsh MEDICAL / Public Health bisacsh Cancer / Treatment fast Clinical trials fast Oncology / Research fast Medizin Cancer Treatment Oncology Research Clinical trials |
| topic_facet | Neoplasms / therapy / United States Clinical Trials as Topic / standards / United States MEDICAL / Preventive Medicine MEDICAL / Forensic Medicine MEDICAL / Public Health Cancer / Treatment Clinical trials Oncology / Research Medizin Cancer Treatment Oncology Research USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=123575 |
| work_keys_str_mv | AT gelbandhellen areportonthesponsorsofcancertreatmentclinicaltrialsandtheirapprovalandmonitoringmechanisms AT nationalcancerpolicyboardus areportonthesponsorsofcancertreatmentclinicaltrialsandtheirapprovalandmonitoringmechanisms |